The information provided regarding the Phase 2 study has been quite general so far. In the interview linked by Sijoittaja-alokas above, Vuolanto mentions that they aim to provide more detailed information about the P2 study design “within the next four weeks,” which likely means going deeper into concrete scientific, clinical, and practical details. One could certainly hope for news regarding the financing arrangements as well, but in my opinion, that is fairly unlikely.
Edit: And naturally, there will likely be more detailed information about the Invidi collaboration, and the audience will have the opportunity to ask questions.